ImetelChat

Thanks 1bordersooner, if nothing else these posts are therapy for me. I know some are understandably reading and growing weary of my droning on, while I can’t promise this will be my last on this subject we can hope. Assuming the “deal” has been through several iterations since recent readouts, I wo...

Phil, thanks for putting music to the numbers in detail. You have further opened the window into how JNJ/Janssen have managed to turn what appeared to become a lemon of a CT into lemonade. They have likely confirmed the powerful capabilities of Imetelstat and finally paved the way to commercial use ...

So the seriously interesting negotiation process continues or not on how to complete the business relationship with JNJ and future development of Imetelstat. Whatever happened in this space leading up to 9/13 CC has continued to demonstrate JS’s metal, as he is dealing with heavy weights in JNJ/Jans...

Okay, thanks for commenting. Those are all fair points and just as my perspective can be disputed, so can most others including the assumptions regarding the senior technical consultant being indicative of absolutely 100% BO, regardless I will leave it there. I will say that JS has been at the helm ...

I do have a few more thoughts on this so will spin this a little more it. So Geron’s management could use the biobucks and the eventual royalties in a wasteful ineffective manner and that is a shareholder morale killer. Okay maybe that would be possible in a couple years when financial resources rea...

Okay, so for me 90+ percent or more of what I worry about doesn’t happen. With that as my guide, I also find that frequently things turn out much better than I expected when the various elements have significant human impacts. So with Imetelstat, I personally see that JS’s Geron has actually perform...

While it may not eliminate any concerns or completely satisfy any of us, I thought I should probably share the response to my email to IR at Geron re: Mr. Rosenfield’s options sale. It is essentially the response I was expecting while hoping for more. My question was: I was wondering if there is an ...

Appreciate your sleuthing! Based on the persistence it certainly seems to be meaningful activity. What are thoughts on possibilities for such activity? Could "right to try" or CT reincarnation have anything to do with it? Whatever it is, I suspect it is a pointer to activity behind the sce...

It is indeed great to see you here MedTechBio. Your knowledge, experience, sleuthing and perspective brings much clarity and confidence in whatever you chose to post. The dry humor helps too!

Thank you tutt for such a kind comment. Yes, definitely sooner rather than later! The "tick tock" of the clock drawing us closer to the CD and beyond is not the same "tick tock" the patients with terminal cancer are hearing. While I must admit, it is certainly difficult at best t...

I have been around math and statistics most of my academic and adult life, including many years building computer models to estimate computer resource requirements based on large corporate businesses, subsidiaries, major projects, etc. These tools, of course, will only take you so far in arriving at...

Thanks, biopearl! Staying focused, thoughtful and appropriate is what many of us are looking for and you have stepped up. Much appreciated!

Well the drama of this game continues through earnings again without the hole cards being revealed. I might wonder how we can get so little information when we are so close to the completed data stack and lift off, but we all know there is so much at stake here for Geron, JNJ/Janssen and of course t...

I do have one theory though, it's about the shorts, of course most here likely have the same theory. Incredible as it might seem, "they" are listening to and taking their queue from AE / AF, ha! How great is that for anyone holding tightly to their GERN stock positions once the squeeze begins.

What are the odds? Well I find it very interesting to read the boards on what everyone thinks the odds are for the CD, various CT designations, NDA’s, timing, etc. And how these odds seem to change with every morsel of news or not. I personally think the odds are 100% on JNJ making a positive CD and...

I have watched the Geron / Imetelstat story play out for several years now and have never heard of an issue. It has been progressively better news from CT readouts regarding treatment of hemo diseases, both safety and efficacy. Certainly in the hemo arena, side effects are known and manageable. Deli...

This news is so shocking to me it literally jumbles my mind. What a great loss to family, friends, this website, all those dealing with the ravages of the hemo cancers. My sincerest condolences to his family, friends and really to all of us who follow his website / chat site and have come to greatly...

Great comments Biopearl, and I for one agree it is helpful for anyone not on Twitter or even following the tweets to be able to have the links here. I believe everyone on this board could benefit by following Sdrawkcabeman's tweets. If one follows your link and just clicks on his tweet id, you will ...

Well first, scottmayhew, I personally don’t think this board is appropriate for political posts of any kind. That's one of the reasons I occasionally post here. Everything we are seeing from Geron / Jansen / JNJ continues to be positive and forward thinking. Defensive, in part, on Geron’s side which...

Watching/listening to the quarterly reports, increasing rates of various healthcare conferences, blogs, scientific papers and efforts on various boards, along with the expanding published timelines on expected events regarding the CTs and CD, even progress regarding FDA policies, it is obvious we ar...